Study Title and Description
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial.
Key Questions Addressed
|3||In adult renal transplants, how do immunosuppressive regimens designed to reduce or eliminate exposure to CNI toxicity compare with each other and with full-dose CNI regimens for health outcomes? AND How does the type of induction agent (including when no induction is used) and the use of concurrent immunosuppressive agents affect outcomes of regimens that reduce or eliminate CNI exposure?|
Primary Publication Information
|Title||Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial.|
|Author||Salvadori M., Scolari MP., Bertoni E., Citterio F., Rigotti P., Cossu M., Dal Canton A., Tisone G., Albertazzi A., Pisani F., Gubbiotti G., Piredda G., Busnach G., Sparacino V., Goepel V., Messa P., Berloco P., Montanaro D., Veroux P., Federico S., Bartezaghi M., Corbetta G., Ponticelli C.|
|Country||Renal Transplant Unit, Careggi University Hospital, Florence, Italy. firstname.lastname@example.org|
Pubmed ID: 19935373
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Comparative Effectiveness of Regimens
Results & Comparisons
No Results found.